About this document
Nejmoa1903307 Appendix by Samuel Bravo is a document available to read on EtoBox.
This supplementary appendix provides additional information related to the study on Apalutamide for metastatic, castration-sensitive prostate cancer, including methods, results, and a list of investigators involved. It details definitions for secondary and exploratory endpoints used in the study, such as time to cytotoxic chemotherapy and time to PSA progression. The document serves to enhance the understanding of the research findings published in the main article.
- Author
- Samuel Bravo
- Language
- EN